Winston Su-Kee Fu's Net Worth

$757 Million

Estimate Recalculated Jul 22, 2024 03:10PM EST

Who is Winston Su-Kee Fu?

Winston Su-Kee Fu has an estimated net worth of $757 Million. This is based on reported shares across multiple companies, which include OCCAM NETWORKS INC/DE, @ROAD, INC, LEADIS TECHNOLOGY INC, Altus Pharmaceuticals Inc., IMPERVA INC, Guidewire Software, Inc., AtriCure, Inc., MAXLINEAR INC, OncoMed Pharmaceuticals Inc, Cepton, Inc., INTERMOLECULAR INC, and NEW FOCUS INC.

SEC CIK

Winston Su-Kee Fu's CIK is 0001225477

Past Insider Trading and Trends

2011 was Winston Su-Kee Fu's most active year for acquiring shares with 19 total transactions. Winston Su-Kee Fu's most active month to acquire stocks was the month of October. 2012 was Winston Su-Kee Fu's most active year for disposing of shares, totalling 48 transactions. Winston Su-Kee Fu's most active month to dispose stocks was the month of October. 2003 saw Winston Su-Kee Fu paying a total of $10,000,000.00 for 1,000,000 shares, this is the most they've acquired in one year. In 2012 Winston Su-Kee Fu cashed out on 21,906,458 shares for a total of $98,431,979.17, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INTERMOLECULAR INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.03%
-1.21K
$6.70
-$8,100.30
4.28M
Jun 14
Form 4
-4.86%
-218.63K
$6.76
-$1,478,268.28
4.28M
Jun 11 - Jun 13
Form 4
-7.00%
-338.50K
$6.55
-$2,217,344.25
4.5M
May 31
Form 4
-10.00%
-537.60K
—
—
4.84M
May 15
Form 4
∞
5.38M
—
—
5.38M
Nov 23
No matching records found

OCCAM NETWORKS INC/DE No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.18M
—
—
0
Feb 22
Form 4
-86.90%
-311.88K
—
—
47.01K
Nov 25
Form 4
-17.80%
-755.22K
$14.32
-$3,952.32
3.49M
Feb 21
Form 4
-7.52%
-309.03K
$13.23
-$4,088,480.13
3.8M
Nov 14
Form 4
+124.57%
2.28M
$13.23
-$8,176,947.03
4.11M
Nov 7
Form 4
—
0
—
—
0
Mar 23
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Jan 7
Form 4
—
0
—
—
0
Nov 19
Form 4
—
0
—
—
0
No matching records found

LEADIS TECHNOLOGY INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-33.31%
-1.01M
—
—
2.02M
Jul 26
Form 4
-24.99%
-1.01M
—
—
3.02M
May 25
Form 4
-19.99%
-1.00M
—
—
4M
Feb 1
Form 4
∞
5.11M
—
—
5.11M
Jun 21
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Altus Pharmaceuticals Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.96%
-300.00K
$0.32
-$97,290.00
2.71M
Sep 14
Form 4
∞
3.01M
—
—
3.01M
Jan 31
Form 3
—
0
—
—
0
No matching records found

AtriCure, Inc. (ATRC) Snapshot price: $33.02

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-18.89%
-352.58K
—
—
1.51M
Jun 13
Form 4
-15.87%
-357.62K
$9.44
-$47,578.88
1.9M
Jun 6 - Jun 7
Form 4
+0.38%
8.47K
$5.62
$14,076.53
2.25M
Aug 10
Form 4
∞
2.24M
$11.16
-$3,037,952.88
2.24M
Aug 10
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found